Deferred Tax Assets, Valuation Allowance of Sensei Biotherapeutics, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sensei Biotherapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Sensei Biotherapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $58,180,000, a 14% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Sensei Biotherapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $58,180,000 +$7,130,000 +14% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $51,050,000 +$9,690,000 +23% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $41,360,000 +$8,209,000 +25% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $33,151,000 +$8,396,000 +34% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $24,755,000 31 Dec 2020 10-K 15 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.